May 15 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has recorded a consolidated net profit of 3.9 million euro ($4.2 million) in the first quarter of 2024, up 39.6% from 2.8 million euro in the like period of last year, it said.